Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001053887 | SCV001218170 | likely benign | Duchenne muscular dystrophy | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002320296 | SCV002632324 | uncertain significance | Cardiovascular phenotype | 2021-03-02 | criteria provided, single submitter | clinical testing | The p.D388Y variant (also known as c.1162G>T), located in coding exon 11 of the DMD gene, results from a G to T substitution at nucleotide position 1162. The aspartic acid at codon 388 is replaced by tyrosine, an amino acid with highly dissimilar properties. Based on data from gnomAD, the T allele has an overall frequency of 0.0005% (1/182852) total alleles studied, with 1 hemizygote observed. The highest observed frequency was 0.001% (1/81534) of non-Finnish European alleles. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001274381 | SCV001458498 | uncertain significance | Dystrophin deficiency | 2020-09-16 | no assertion criteria provided | clinical testing |